FDA Adverse Event Other Summary report: N

NOVAMAX LINK GLUCOSE MONITOR

MDR report key: 3777909 · Received April 22, 2014

Report

Report Number
3004193489-2014-00023
Event Type
Other
Date Received
April 22, 2014
Date of Event
March 29, 2014
Report Date
March 29, 2014
Manufacturer
NOVA BIOMEDICAL CORP.
Product Code
NBW
PMA / PMN Number
K040603
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

NOVA BIOMEDICAL AWAITS THE RETURN OF THE DEVICE FOR EVALUATION. SHOULD ANY SIGNIFICANT FINDINGS BE A RESULT OF THAT INVESTIGATION, A FOLLOW-UP REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO NOVA BIOMEDICAL THAT A CONSUMER STATED, "EMT SERVICE WAS CALLED TO HER HOME DUE TO HER BEING FOUND UNRESPONSIVE THIS MORNING BY HER HUSBAND." IT WAS REPORTED THAT A CONSUMER RECEIVED A RESULT OF 86 MG/DL ON HER BLOOD GLUCOSE METER. THE CONSUMER IMMEDIATELY PERFORMED TWO ADDITIONAL TESTS USING THE SAME METER AND STRIPS FROM THE SAME VIAL GETTING THE FOLLOWING RESULTS OF 260 MG/DL AND 66 MG/DL. THE CONSUMER EXPERIENCED A HYPOGLYCEMIC EVENT WHICH REQUIRED BOTH EMERGENT FOOD INTERVENTION TO HELP RAISE HER BLOOD SUGAR LEVEL AND WHEN THE EMTS ARRIVED, THEY OBSERVED AND DID NOT TREAT THIS CONSUMER. DURING THE CALL TO CUSTOMER SUPPORT, IT WAS REVEALED THAT THE CONSUMER DID NOT CONTROL SOLUTION TEST FOR INTEGRITY BEFORE USE THEIR INITIAL TEST STRIPS AS INSTRUCTED IN OUR DIRECTIONS FOR USE. A CONTROL SOLUTION TEST WAS PERFORMED WHILE TROUBLESHOOTING WITH CUSTOMER SUPPORT SHOWING THE TEST STRIPS TO FALL IN RANGE. THE DIFFERENCE IN THE CONSUMER'S READINGS WAS DETERMINED TO BE CLINICALLY SIGNIFICANT. THE METER AND TESTS STRIPS WILL BE RETURNED FOR EVALUATION. TEST STRIP LOT NUMBER 1020213155, EXPIRATION DATE: 06/2015. CONTROL SOLUTION LOT: 1030713254, RANGE: 82-127 MG/DL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
244522 NOVAMAX LINK GLUCOSE MONITOR GLUCOSE MONITOR NBW NOVA BIOMEDICAL CORP. NA 1020213155

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention